<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Paresh G. Koli</style></author><author><style face="normal" font="default" size="100%">Yashashri Shetty</style></author><author><style face="normal" font="default" size="100%">Reetu Sharma</style></author><author><style face="normal" font="default" size="100%">Bal Krishan Sevatkar</style></author><author><style face="normal" font="default" size="100%">Anaya A. Pathrikar</style></author><author><style face="normal" font="default" size="100%">Hemant S. Paradkar</style></author><author><style face="normal" font="default" size="100%">Mukesh B Chawda</style></author><author><style face="normal" font="default" size="100%">Sangam S. Narvekar</style></author><author><style face="normal" font="default" size="100%">Megha L. Nalawade</style></author><author><style face="normal" font="default" size="100%">Pawankumar R. Godatwar</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">A Prospective, Multi-centre, Open label, Single arm Study to Evaluate the Efficacy and Safety of Amlapitta Mishran Suspension in Participants with Amlapitta (Symptomatic Gastritis)</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Ayurveda</style></keyword><keyword><style  face="normal" font="default" size="100%">Gastritis</style></keyword><keyword><style  face="normal" font="default" size="100%">Symptom scores</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2025</style></year><pub-dates><date><style  face="normal" font="default" size="100%">September 2025</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">17</style></volume><pages><style face="normal" font="default" size="100%">545-551</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Introduction: &lt;/strong&gt;The multi-center clinical study was conducted to revalidate the efficacy and safety of Amlapitta Mishran Suspension in Amlapitta (symptomatic gastritis) in a larger sample size in improving Amlapitta Symptom Rating Scale Score, PPDS score, EPS score, and safety. &lt;strong&gt;Methods: &lt;/strong&gt;The study was a multi-centric, open-labeled, single-arm, prospective clinical trial in participants with Amlapitta (symptomatic gastritis). Participants with the presence of Amlapitta (symptomatic gastritis), as diagnosed by the Amlapitta Symptom Rating Scale Score ≥ 5 were included in the study. Participants were advised to take Amlapitta Mishran Suspension in a dose of 15 ml twice daily for 14 days. The study involved three visits. The investigator recorded the Amlapitta Symptom Rating Scale (ASRS) Score, Post Prandial Distress Syndrome (PPDS) Score, and Epigastric Pain Syndrome (EPS) Score at screening visit (Visit 1), baseline visit (Visit 2) and final visit (Visit 3). The p&amp;lt;0.05 was considered statistically significant measured by paired t-test or Wilcoxon Signed Rank test. &lt;strong&gt;Results: &lt;/strong&gt;In the multi-center study 204 participants completed the study. At final visit, a statistically significant (p&amp;lt;0.001) reduction was reported in mean Total ASRS score, PPDS score, and EPS score as compared to the baseline scores. The individual ASRS, PPDS, and EPS variables also exhibited significant reduction (p&amp;lt;0.001) at the final visit. None of the participants reported any adverse events during the study. &lt;strong&gt;Conclusion: &lt;/strong&gt;Amlapitta Mishran Suspension treatment for 14 days effectively and safely reduced the clinical symptoms of Amlapitta (symptomatic gastritis) assessed by Amlapitta Symptom Rating Scale, Postprandial Distress Syndrome and Epigastric Pain Syndrome scores.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">5</style></issue><work-type><style face="normal" font="default" size="100%">Original Article</style></work-type><section><style face="normal" font="default" size="100%">545</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Paresh G. Koli&lt;sup&gt;1*,&lt;/sup&gt; Yashashri Shetty&lt;sup&gt;1&lt;/sup&gt;, Reetu Sharma&lt;sup&gt;2&lt;/sup&gt;, Bal Krishan Sevatkar&lt;sup&gt;2&lt;/sup&gt;, Anaya A. Pathrikar&lt;sup&gt;3&lt;/sup&gt;, Hemant S. Paradkar&lt;sup&gt;3&lt;/sup&gt;, Mukesh B Chawda&lt;sup&gt;4&lt;/sup&gt;, Sangam S. Narvekar&lt;sup&gt;5&lt;/sup&gt;, Megha L. Nalawade&lt;sup&gt;6&lt;/sup&gt;, Pawankumar R. Godatwar&lt;sup&gt;7&lt;/sup&gt; &lt;/strong&gt;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;1&lt;/sup&gt;Department of Pharmacology and Therapeutics, Seth GS Medical College and KEM Hospital, Mumbai. INDIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;2&lt;/sup&gt;Department of Roga Nidana Evum Vikriti Vigyana, National Institute of Ayurveda, Madhav Vilas Palace, Jorawar Singh Gate Amer Road, Jaipur - 302 002. INDIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;3&lt;/sup&gt;Department of Kayachikitsa, Ayurvidya Prasarak Mandal’s, Seth R.V. Ayurvedic Hospital, Sion (E), Mumbai - 400 022. INDIA&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;4&lt;/sup&gt;Medical Services, Solumiks Herbaceuticals Limited, 135, Nanubhai Desai Road, Khetwadi, Mumbai - 400 004. INDIA&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;5&lt;/sup&gt;Medical Services, Shree Dhootapapeshwar Limited, 135, Nanubhai Desai Road, Khetwadi, Mumbai – 400 004. INDIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;6&lt;/sup&gt;Shree Dhootapapeshwar Limited, 135, Nanubhai Desai Road, Khetwadi, Mumbai - 400 004. INDIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;7&lt;/sup&gt;Department of Roga Nidana Evum Vikriti Vigyana, National Institute of Ayurveda, Madhav Vilas Palace, Jorawar Singh Gate, Amer Road Jaipur - 302 002. INDIA.&lt;/p&gt;
</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Herra Studiawan</style></author><author><style face="normal" font="default" size="100%">Sukardiman</style></author><author><style face="normal" font="default" size="100%">Indana Lazulfa</style></author><author><style face="normal" font="default" size="100%">Rosita Handayani</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Anti-Gastritis Activity of Cloves (Eugenia caryophyllata Thunberg) and Lime (Citrus aurantifolia) Leaf Extracts Combination in Absolute Alcohol Induced-Gastric Injury Mice</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Citrus aurantifolia</style></keyword><keyword><style  face="normal" font="default" size="100%">Clove</style></keyword><keyword><style  face="normal" font="default" size="100%">Eugenia caryophyllata</style></keyword><keyword><style  face="normal" font="default" size="100%">Gastritis</style></keyword><keyword><style  face="normal" font="default" size="100%">Lime</style></keyword><keyword><style  face="normal" font="default" size="100%">Ulcer</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2023</style></year><pub-dates><date><style  face="normal" font="default" size="100%">June 2023</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">15</style></volume><pages><style face="normal" font="default" size="100%">378-384</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Background: &lt;/strong&gt;Clove (&lt;em&gt;Eugenia caryophyllata &lt;/em&gt;Thunberg) and lime (&lt;em&gt;Citrus aurantifolia&lt;/em&gt;) are medicinal plants traditionally used to treat various diseases such as gastritis. Some studies reported that cloves leaf and lime leaf extract showed a gastroprotective effect by decreasing the gastric acid secretion and increasing the gastric mucus.&lt;strong&gt; Aim: &lt;/strong&gt;This study aims to investigate the anti-gastritis activity of the combination of ethanolic extract of cloves leaf and lime leaf extract in alcohol absolute-induced mice. &lt;strong&gt;Methods: &lt;/strong&gt;Mice were treated with the combination extract 0.7 g/kg BW, 1.4 g/kg BW, and 2.8 g/kg BW. Famotidine was used as a positive control, and Na CMC suspension was used as a negative control. After 45 minutes of oral administration, 0.14 ml/20g BW alcohol absolute was given to all mice. All groups were sacrificed one hour later. The evaluation showed that extract combination in all doses significantly decreased ulcer index (UI) compared to a negative control group (p&amp;lt;0.005) in macroscopic evaluation. &lt;strong&gt;Results: &lt;/strong&gt;In histopathologic evaluation, all doses significantly decreased mucosal edema and epithelial cell loss (p&amp;lt;0.005), but in gastric bleeding evaluation, only 0.7 and 1.4 g/kg BW doses showed a significant decrease. &lt;strong&gt;Conclusion&lt;/strong&gt;: This study showed that a combination of clove and lime leaf extracts has anti-gastritis activity and could be a possible therapeutic of anti-gastritis. The most effective dose is 1.4 g/kg BW in mice which showed the lowest ulcer index and gastric mucosal edema, bleeding and epithelial cells loss reduction on histopathological observation.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">3</style></issue><work-type><style face="normal" font="default" size="100%">Research Article</style></work-type><section><style face="normal" font="default" size="100%">378</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Herra Studiawan, Sukardiman*, Indana Lazulfa, Rosita Handayani&lt;/strong&gt;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;Pharmaceutical Science Department, Faculty of Pharmacy, Airlangga University, Surabaya, East Java, INDONESIA&lt;/p&gt;
</style></auth-address></record></records></xml>